Urging The Department Of Health, Department Of The Attorney General, And Department Of Law Enforcement To Coordinate An Enforcement Plan To Address The Lack Of Enforceable Compliance, Rules, And Regulations Regarding The Surge Of Illegal Dispensary Operators That Sell Cannabis Labeled As Hemp.
HCR147 is a nonbinding House Concurrent Resolution that urges the Hawaii Department of Health, the Department of the Attorney General, and the Department of Law Enforcement to coordinate an enforcement plan to address illegal dispensary operators that are allegedly selling cannabis products labeled as hemp. The resolution frames the issue as a growing public health and safety problem, describing a surge of unregulated operators, including online and delivery sellers, and noting that these businesses may be operating near schools, playgrounds, public housing, and other sensitive locations.
The measure explains the legal distinction between hemp and cannabis based on THC content and emphasizes that product testing is necessary to verify compliance. It also points to the current regulatory structure, under which hemp production is overseen by the Department of Agriculture while medical cannabis is regulated by the Department of Health, and argues that no single agency is clearly responsible for illicit cannabis enforcement. The resolution specifically urges the Department of Health to use its authority under chapter 328G, Hawaii Revised Statutes, and chapter 11-37, Hawaii Administrative Rules, to stop the proliferation of cannabis mislabeled as hemp, while acknowledging that there are no specific statutes directly governing illegal dispensaries at this time.
Because HCR147 is a concurrent resolution rather than a bill, it does not change state law or create new penalties, licensing requirements, or enforcement powers. Its practical effect is advisory: it seeks to prompt interagency coordination among DOH, the Attorney General, and DLE, and to encourage use of existing authority under hemp and medical cannabis laws to address alleged loopholes in enforcement. The resolution also highlights a perceived gap in statutory coverage for illicit dispensaries and may influence future legislative or administrative action on hemp-derived intoxicants, delta-8 THC, and unlicensed cannabis sales.
The overall sentiment in the resolution is strongly supportive of enforcement action and highly concerned about the public health and safety risks posed by illegal dispensaries. The bill’s findings portray the problem as rapidly expanding and urgent, and the language used is emphatic, describing the situation as an epidemic. No committee transcript or vote record was provided, so there is no recorded opposition or amendment history to indicate divided views in formal debate.
The main point of contention is the regulatory gray area between lawful hemp commerce and unlawful cannabis sales, especially products marketed as hemp but allegedly containing intoxicating levels of THC. The resolution suggests that enforcement is difficult because responsibilities are spread across multiple agencies and because there are no specific statutes aimed at illegal dispensaries. Implicitly, the issue may also raise concerns for hemp businesses and consumers who rely on hemp-derived products, since stricter enforcement or broader THC restrictions could affect legitimate commerce as well as illicit operators.